BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 18522312)

  • 21. Introduction of human papillomavirus (HPV) vaccination in Belgium, 2007-2008.
    Simoens C; Sabbe M; Van Damme P; Beutels P; Arbyn M
    Euro Surveill; 2009 Nov; 14(46):. PubMed ID: 19941796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Middle school vaccination requirements and adolescent vaccination coverage.
    Bugenske E; Stokley S; Kennedy A; Dorell C
    Pediatrics; 2012 Jun; 129(6):1056-63. PubMed ID: 22566425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries.
    Goldie SJ; O'Shea M; Campos NG; Diaz M; Sweet S; Kim SY
    Vaccine; 2008 Jul; 26(32):4080-93. PubMed ID: 18550229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reported adverse events in girls aged 13-16 years after vaccination with the human papillomavirus (HPV)-16/18 vaccine in the Netherlands.
    van Klooster TM; Kemmeren JM; van der Maas NA; de Melker HE
    Vaccine; 2011 Jun; 29(28):4601-7. PubMed ID: 21549785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human papillomavirus vaccine coverage among female Australian adolescents: success of the school-based approach.
    Brotherton JM; Murray SL; Hall MA; Andrewartha LK; Banks CA; Meijer D; Pitcher HC; Scully MM; Molchanoff L
    Med J Aust; 2013 Nov; 199(9):614-7. PubMed ID: 24182228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coverage from Ontario, Canada's school-based HPV vaccine program: the first three years.
    Wilson SE; Harris T; Sethi P; Fediurek J; Macdonald L; Deeks SL
    Vaccine; 2013 Jan; 31(5):757-62. PubMed ID: 23246265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HPV vaccination catch up program - utilisation by young Australian women.
    Weisberg E; Bateson D; McCaffery K; Skinner SR
    Aust Fam Physician; 2009; 38(1-2):72-6. PubMed ID: 19283241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measuring human papillomavirus (HPV) vaccination coverage and the role of the National HPV Vaccination Program Register, Australia.
    Gertig DM; Brotherton JM; Saville M
    Sex Health; 2011 Jun; 8(2):171-8. PubMed ID: 21592430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uptake of the human papillomavirus-vaccination within the free-of-charge childhood vaccination programme in Denmark.
    Widgren K; Simonsen J; Valentiner-Branth P; Mølbak K
    Vaccine; 2011 Dec; 29(52):9663-7. PubMed ID: 22015392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adolescent and young adult HPV vaccination in Australia: achievements and challenges.
    Garland SM; Skinner SR; Brotherton JM
    Prev Med; 2011 Oct; 53 Suppl 1():S29-35. PubMed ID: 21962468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human papillomavirus and papillomavirus vaccines: knowledge, attitudes and intentions of general practitioners and practice nurses in Christchurch.
    Henninger J
    J Prim Health Care; 2009 Dec; 1(4):278-85. PubMed ID: 20690336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunisation coverage of adults: a vaccination counselling campaign in the pharmacies in Switzerland.
    Valeri F; Hatz C; Jordan D; Leuthold C; Czock A; Lang P
    Swiss Med Wkly; 2014; 144():w13955. PubMed ID: 24782107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. "Is cancer contagious?": Australian adolescent girls and their parents: making the most of limited information about HPV and HPV vaccination.
    Cooper Robbins SC; Bernard D; McCaffery K; Brotherton J; Garland S; Skinner SR
    Vaccine; 2010 Apr; 28(19):3398-408. PubMed ID: 20199758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted cervical cancer vaccine coadministered with combined diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine to girls and young women.
    Garcia-Sicilia J; Schwarz TF; Carmona A; Peters K; Malkin JE; Tran PM; Behre U; Iturbe EB; Catteau G; Thomas F; Dobbelaere K; Descamps D; Dubin G;
    J Adolesc Health; 2010 Feb; 46(2):142-51. PubMed ID: 20113920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delivery of hepatitis B immunisations in a selection of computerised general practices.
    Wilson N; Dovey S; Bandaranayake D; Tilyard M
    N Z Med J; 1995 Feb; 108(993):34-6. PubMed ID: 7891933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Vaccination among students in grades 6-10, 2011 - a comparison of German states: need for action for a targeted nationwide immunisation strategy].
    Ellsäßer G; Trost-Brinkhues G
    Gesundheitswesen; 2013 Nov; 75(11):705-13. PubMed ID: 24203686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. National and state vaccination coverage among adolescents aged 13-17 years--United States, 2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Aug; 61(34):671-7. PubMed ID: 22932301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human papillomavirus immunisation of adolescent girls and anticipated reporting of immune-mediated adverse events.
    Callréus T; Svanström H; Nielsen NM; Poulsen S; Valentiner-Branth P; Hviid A
    Vaccine; 2009 May; 27(22):2954-8. PubMed ID: 19428906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High HPV vaccine acceptance despite low awareness among Swedish upper secondary school students.
    Gottvall M; Larsson M; Höglund AT; Tydén T
    Eur J Contracept Reprod Health Care; 2009 Dec; 14(6):399-405. PubMed ID: 19929642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The predicted impact of HPV vaccination on male infections and male HPV-related cancers in Australia.
    Smith MA; Lew JB; Walker RJ; Brotherton JM; Nickson C; Canfell K
    Vaccine; 2011 Nov; 29(48):9112-22. PubMed ID: 21419773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.